Patents Assigned to PHUSIS THERAPEUTICS, INC.
  • Compounds, compositions and methods for inhibiting CNKSR1
    Patent number: 10227356
    Abstract: Compounds that inhibit CNKSR1, pharmaceutical compositions including compounds that inhibit CNKSR1 and methods of treating disease or disorders that respond to CNKSR1 inhibition are described herein. Additionally, methods of identifying inhibitors of CNKSR1 are described.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: March 12, 2019
    Assignee: PHUSIS THERAPEUTICS, INC.
    Inventors: D. Lynn Kirkpatrick, Martin Indarte
  • COMPOUNDS, COMPOSITIONS AND METHODS FOR INHIBITING CNKSR1
    Publication number: 20160304533
    Abstract: Compounds that inhibit CNKSR1, pharmaceutical compositions including compounds that inhibit CNKSR1 and methods of treating disease or disorders that respond to CNKSR1 inhibition are described herein. Additionally, methods of identifying inhibitors of CNKSR1 are described.
    Type: Application
    Filed: April 20, 2016
    Publication date: October 20, 2016
    Applicant: Phusis Therapeutics, Inc.
    Inventors: D. Lynn KIRKPATRICK, Martin INDARTE
  • Methods and compositions for inhibiting CNKSR1
    Patent number: 9340532
    Abstract: Embodiments include compositions and methods of inhibiting CNKSR1 and methods of identifying inhibitors of CNKSR1.
    Type: Grant
    Filed: December 16, 2013
    Date of Patent: May 17, 2016
    Assignee: Phusis Therapeutics, Inc.
    Inventors: D. Lynn Kirkpatrick, Martin Indarte, Nathan T. Ihle
  • METHODS AND COMPOSITIONS FOR INHIBITING CNKSR1
    Publication number: 20150307482
    Abstract: Embodiments include compositions and methods of inhibiting CNKSR1 and methods of identifying inhibitors of CNKSR1.
    Type: Application
    Filed: December 16, 2013
    Publication date: October 29, 2015
    Applicant: PHUSIS THERAPEUTICS, INC.
    Inventors: D. LYNN KIRKPATRICK, MARTIN INDARTE, NATHAN T. IHLE